Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • BioLargo, Inc. (BLGO) Builds On Patented Technology To Deliver Array Of Safe, Efficient Solutions To Improve Quality Of Life 1 comment
    Jan 29, 2014 5:33 PM | about stocks: BLGO

    Kenneth Reay Code's father had a stroke nearly a decade ago, leaving him significantly impaired. This limited mobility put his father in a risky position of needing long-term convalescent care where he would be exposed to the risks of secondary infection often faced in a care facility. Concerned about the legitimate risks to his father's health, Code was determined to improve his father's quality of life and extend his life expectancy by reducing the compounding risks of secondary infection. The result of this determination was BioLargo Technology, a blend of inorganic chemical compound and absorbent materials used as an effective instrument in preventing the transmission of life threatening infection.

    The BioLargo Technology places basic, safe, and inorganic compounds into absorbent products found in healthcare environments, such as bed pads, blood pads, diapers, surgical drapes, transportation packages for protective liners, wound dressings, bandages, etc. The technology can also be also placed in liquid, tablet, powders, sprays, washes, and gas phase delivery systems.

    When the BioLargo Technology is incorporated into these types of products, the results are potent, safe, and degradable germ killing products that mitigate the often fatal risks of infection.

    Now a publicly traded company, BioLargo holds five issued U.S. patents and is on record with more than 20 additional patent applications at the U.S. Patent and Trademark Office relating to additional uses of the chemistry, the reactions and the applications of the BioLargo Technology. Utilizing this technology, BioLargo is developing products and services offered through several company subsidiaries subsidiaries.

    BioLargo Water is focused on Advanced Oxidation Systems (NYSE:AOS) such as the AOS Filter, a development-stage product designed to eliminate common toxic contaminants found in water in a more time efficient and less expensive manner than current technologies. BioLargo also owns a 50 percent interest in the Isan System, which was given the "Top 50 Water Company for the 21st Century" award by the Artemis Project. The subsidiary Odor-No-More Inc. offers products serving the pet, equine, and consumer markets, including the Nature's Best Solution® and Deodorall® brands. The Clyra Medical Technologies, Inc. subsidiary focuses on advanced wound care management and is preparing to make U.S. FDA 510(k) applications in 2014.

    For more information, visit biolargo.com

    QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net

    Stocks: BLGO
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (1)
Track new comments
  • RJM2
    , contributor
    Comments (644) | Send Message
     
    Dennis Calverts long term track record of value destruction a $64.53 million loss
    .

     

    Starting at 6/30/02 which is right after Denny-boy took over, the company had an accumulated deficit of $12.919 million.

     

    At 6/3-/14, a full 12 years under Calverts expert leadership, the company now has an accumulated deficit of $77.448 million.

     

    That means in his 12 years at the helm, he has burned $64.529 million. Or an average of $5.377 million per year.

     

    It went from Nuway Energy to Nuway Medical to Biolargo.

     

    They have never had any revenue to speak of. But they have managed to lose $64+ million while Calvert lives like a king.

     

    The reason its being hyped so hard right now is they have managed to issue a boatload of private placement shares and warrants in the 20-30 cent range and those people need you to sell to.

     

    Yes, you are the patsies who allow Calvert to blow $64.5 million over 12 years, changing businesses multiple times with dozens or even hundreds of material misleading press releases along the way
    17 Aug 2014, 09:33 AM Reply Like
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.